Complaint Counsel's Post Trial Brief - Federal Trade Commission

427. LaMont ''would be concerned about patients takg (7 Herb Formula) on its own and
expecting their cancer to go away." (R22 (LaMont, Dep. at 118)).
428. LaMont stated that "(i)t would be a stretch for (her) that (7 Herb Formula) is a solution to
cancer." (R22 (LaMont, Dep. at 120)).
429. Lamont ''would be surrised if
(LaMont, Dep. at 120)).
(7 Herb Formula) itself
is the solution to cancer." (R22
430. LaMont would have a concer if7 Herb Formula was adverised as a cancer solution.
(R22 (LaMont, Dep. at 120-21, 123)).
431. LaMont does not know whether the amount of cat's claw in 7 Herb Formula is going to
be effective. (R22 (LaMont, Dep. at 129)).
432. LaMont acknowledged that we do not know whether 7 Herb Formula as an independent
agent would have any beneficial effects in respect to ovaran cancer. (R22 (LaMont,
Dep. at 137)).
433. LaMont personally has never used any of
(LaMont, Dep. at 150)).
the essiac tea formulas in her practice. (R22
434. LaMont does not thi it is a good idea to take 7 Herb or GDU instead of havig a polyp
in the colon cut out. (R22 (LaMont, Dep. at 182-83)).
GDU
James Duke. Ph.D.
435. Duke does not know how much of
the elements that are in GDU are actually in the
product sold by DCO. (R18 (Duke, Dep. at 78); Duke, Tr. 533).
436. Duke testified that he saw two or thee studies on tueric, "but they were not
conclusive." (R18 (Duke, Dep. at 120); Duke, Tr. 533).
437. Duke is not sure whether tuerc is more effective in fighting cancer than curcumin in
an isolated form. (R18 (Duke, Dep. at 137)).
438. Duke does not remember any clinical studies on Bromelai. (R18 (Duke, Dep. at 124);
Duke, Tr. 533).
439. Duke testified that Feverew is "not the first thing I th about when I'm thg
cancer." (R18 (Duke, Dep. at 129-130)).
440. There are no clinical trals regarding pineapple Bromelain's effcacy as to cancer in
Duke's IE. (R18 (Duke, Dep. at 148)).
441. Based on his review, there are no clinical trals regarding tuerc's effcacy as to cancer
in Duke's IE. (R18 (Duke, Dep. at 153); Duke, Tr. 533).
37